Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Ziegler

Showing results (111-120 of 1,099) with videos related to

Pageof 110
Sort By:
Klinische Wochenschrift|January 1, 1990
[Type III hyperlipoproteinemia in idiopathic hemochromatosis]G Feussner, R Ziegler
Der Orthopade|June 9, 1998
[Biphosphonate therapy in the management of skeletal metastases]A Grauer, R Ziegler
European Journal of Endocrinology|January 1, 1997
Suppression of serum thyrotropin with thyroxine in patients with Graves' disease: effects on recurrence of hyperthyroidism and thyroid volumeJ Pfeilschifter, R Ziegler
Der Internist|May 1, 1996
[Bone metabolism and disorders]F Raue, R Ziegler
Der Orthopade|November 1, 1996
[Bone metabolism and diseases]F Raue, R Ziegler
Clinical Endocrinology|October 1, 1996
Smoking and endocrine ophthalmopathy: impact of smoking severity and current vs lifetime cigarette consumptionJ Pfeilschifter, R Ziegler
Der Radiologe|September 1, 1984
[Paget disease of the skeleton. Internal medicine aspects]R Ziegler, G Baldauf
Journal of Internal Medicine|August 1, 1991
Expression of type III hyperlipoproteinaemia in a subject with secondary hypothyroidism bearing the apolipoprotein E2/2 phenotypeG Feussner, R Ziegler
Deutsche Krankenpflegezeitschrift|January 1, 1992
[Hyperparathyroidism: pathology, diagnosis and therapy]C Wüster, R Ziegler
European Journal of Endocrinology|July 25, 1998
Relationship between IGF-I and skeletal agingJ Pfeilschifter, R Ziegler
Pageof 110

Showing results (111-120 of 1,099) with videos related to

Sort By:
Pageof 110
Klinische Wochenschrift|January 1, 1990
[Type III hyperlipoproteinemia in idiopathic hemochromatosis]G Feussner, R Ziegler
Der Orthopade|June 9, 1998
[Biphosphonate therapy in the management of skeletal metastases]A Grauer, R Ziegler
European Journal of Endocrinology|January 1, 1997
Suppression of serum thyrotropin with thyroxine in patients with Graves' disease: effects on recurrence of hyperthyroidism and thyroid volumeJ Pfeilschifter, R Ziegler
Der Internist|May 1, 1996
[Bone metabolism and disorders]F Raue, R Ziegler
Der Orthopade|November 1, 1996
[Bone metabolism and diseases]F Raue, R Ziegler
Clinical Endocrinology|October 1, 1996
Smoking and endocrine ophthalmopathy: impact of smoking severity and current vs lifetime cigarette consumptionJ Pfeilschifter, R Ziegler
Der Radiologe|September 1, 1984
[Paget disease of the skeleton. Internal medicine aspects]R Ziegler, G Baldauf
Journal of Internal Medicine|August 1, 1991
Expression of type III hyperlipoproteinaemia in a subject with secondary hypothyroidism bearing the apolipoprotein E2/2 phenotypeG Feussner, R Ziegler
Deutsche Krankenpflegezeitschrift|January 1, 1992
[Hyperparathyroidism: pathology, diagnosis and therapy]C Wüster, R Ziegler
European Journal of Endocrinology|July 25, 1998
Relationship between IGF-I and skeletal agingJ Pfeilschifter, R Ziegler
Pageof 110